Characteristics and outcomes of extracorporeal life support in pediatric trauma patients

Christopher A Behr1, Stephen J Strotmeyer, Justyna Swol

  • 1From the UPMC Children's Hospital of Pittsburgh (C.A.B., S.J.S., B.A.G.), Pittsburgh, Pennsylvania; and General Hospital Nuremberg (J.S.), University Hospital of Paracelsus Medical University, Nuremberg, Germany.

Insights

Pediatric trauma patients on extracorporeal membrane oxygenation (ECMO) show comparable survival and complication rates to other indications. Trauma is not a contraindication for ECMO in children.

Area of Science:

  • Pediatric Critical Care Medicine
  • Extracorporeal Life Support
  • Trauma Management

Background:

  • Extracorporeal membrane oxygenation (ECMO) is established for pediatric use but understudied in trauma.
  • Limited data exists on ECMO indications, characteristics, and outcomes in pediatric trauma patients.

Purpose of the Study:

  • To examine the indications, characteristics, and outcomes of pediatric trauma patients treated with ECMO.
  • To compare outcomes of pediatric trauma patients on ECMO to those on ECMO for other conditions.

Main Methods:

  • Retrospective review of the Extracorporeal Life Support Organization registry (1989-2018).
  • Analysis of 573 pediatric trauma patients, stratified by ECMO mode (VV, VA, conversion).
  • Examination of patient demographics, indications, complications, and survival rates.

Main Results:

  • Drowning, burns, and thoracic trauma were leading mechanisms.
  • High complication rates (81.9%) were observed, similar to other ECMO cohorts.
  • Overall survival was 55.3%, with significantly higher survival on venovenous (VV) ECMO (74.3%) versus veno-arterial (VA) ECMO (41.7%).

Conclusions:

  • Pediatric trauma patients on ECMO have survival and complication rates comparable to other indications.
  • Extracorporeal membrane oxygenation (ECMO) should not be contraindicated in pediatric trauma cases.
Abstract

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
436
Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
441
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
448